Biosimilars
Drug Development/R&D
All Topics

Newsletter SignupSubscribe

Search publications, topics, authors and more

News & Insights

News
Events
Insights
Bulletin

News
Events
Insights
Bulletin

News & Insights

News
Events
Insights
Bulletin

Newsletter SignupSubscribe

News
Events
Insights
Bulletin

Search publications, topics, authors and more

Close

Research & Publications
News & Insights
Education
Innovation Policy Prize

Events
About Us
OHE Experts
Contact Us

Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:

Biosimilars
Cell and Gene Therapies
Chronic Diseases
Combination Therapies
Countering AMR
COVID-19 Research
Digital Therapies
Drug Development/R&D
Emerging Markets
EQ-5D and PROMs
Health Care Systems
Health Data and Statistics
Health Technology Assessment
Precision Medicine
Real World Evidence
Use of Medicines
Value-Based Pricing
Vaccine Research

Economics of Innovation
Measuring and Valuing Outcomes
Policy, Organisation and Incentives in Health Systems
Value, Affordability and Decision Making

News & Insights

News
Events
Insights
Bulletin

Education

Education Hub
OHE Graduate School
EVIA Programme

Innovation Policy Prize

The Prize Fund
2022 Prize Fund

Search publications, topics, authors and more

Latest Research & Publications

Health Technology Assessment…
Measuring and Valuing Outcomes
Amgen

Why we need a new Outcomes-based Value Attribution Framework for Combination Regimens in Oncology

Why we need a new Outcomes-based Value Attribution Framework for Combination Regimens in OncologyRead more

2019 OHE Annual Report to the Charity Commission

2019 OHE Annual Report to the Charity CommissionRead more

Measuring and Valuing Outcomes
Clinical Outcomes

Drop Dead: Is Anchoring at ‘Dead’ a Theoretical Requirement in Health State Valuation?

Drop Dead: Is Anchoring at ‘Dead’ a Theoretical Requirement in Health State Valuation?Read more

© freshidea

Measuring and Valuing Outcomes
Clinical Outcomes

How do we Measure the “Value” in Value-Based care?

How do we Measure the “Value” in Value-Based care?Read more

© Dominique James

EFPIA

Opportunities to Increase Efficiency in Healthcare

Opportunities to Increase Efficiency in HealthcareRead more

Value, Affordability, and…
Institute for Clinical and…

Cornerstones of “Fair” Drug Coverage: Appropriate Cost – Sharing and Utilization Management Policies for Pharmaceuticals

Cornerstones of “Fair” Drug Coverage: Appropriate Cost – Sharing and Utilization Management Policies for PharmaceuticalsRead more

Value, Affordability, and…

THE BRAVE INITIATIVE. The BRAVE Narrative for Broad Recognition of Value in Vaccines Engagement.

THE BRAVE INITIATIVE. The BRAVE Narrative for Broad Recognition of Value in Vaccines Engagement.Read more

Health Technology Assessment…
Value, Affordability, and…
Canada

Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Therapies

Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent TherapiesRead more

01
02
03
04
05
06
07
08
00

Close

All Publications

Filter by:

Biosimilars

Cell and Gene Therapies

Chronic Diseases

Combination Therapies

Countering AMR

COVID-19 Research

Digital Therapies

Drug Development/R&D

Emerging Markets

EQ-5D and PROMs

Health Care Systems

Health Data and Statistics

Health Technology Assessment

Precision Medicine

Real World Evidence

Use of Medicines

Value-Based Pricing

Vaccine Research

Economics of Innovation

Measuring and Valuing Outcomes

Policy, Organisation and Incentives in Health Systems

Value, Affordability and Decision Making
News

Events

Insights

Bulletin
Education Hub

OHE Graduate School

EVIA Programme
The Prize Fund

2022 Prize Fund

Events
About Us
OHE Experts
Contact Us

Newsletter SignupSubscribe

OHE Newsroom

Comment, press releases and other news from OHE.

News
January 2023

Professor Aidan Hollis wins first £40,000 OHE Policy Innovation Prize

Krankenschwestern mit Arzt, Generative KI

Blog
May 2022

Ignoring the needs of our future workforce could have disastrous consequences for the UK NHS and its patients.

Filter results by

Topic

Select the product option you would like to filter Topic

Antimicrobial Resistance (AMR) Biosimilars Cell and Gene Therapies Chronic Diseases Combination Therapies COVID-19 Research Digital Therapies Drug Development/R&D Emerging Markets EQ-5D and PROMs Health Data and Statistics Health Technology Assessment (HTA) Healthcare Systems Innovation Policy Prize OHE Consulting Precision Medicine Real World Evidence (RWE) Research Use of Medicines Vaccines Value-Based Pricing

Date 1

Select the product option you would like to filter Date

Date From

Month From

Year From

Date To

Month To

Year To

News
February 2020

A Final MVAC Blueprint—and the Start of an R&D Revolution?

News
January 2020

Anchoring Latent Scale Values for the EQ-5D-Y at 0 = Dead

News
January 2020

OHE Lunchtime Seminar: Personalised Medicine: Is it an oil-rush or oil-spill?

News
January 2020

Ethical and Economic Issues in the Appraisal of Medicines for Ultra-rare (or Ultra-orphan) Conditions

News
January 2020

Funding Challenges in the Malaysian Health Care System

News
January 2020

OHE at HESG Winter 2020

News
December 2019

OHE Presents at Global AMR R&D Hub Board of Members Meeting in Paris

News
December 2019

New OHE Research Funding: Improving Labour Productivity in Primary Care

News
November 2019

OHE has an Opening for an Industrial Economist

News
October 2019

Press Release: Proposed International Price Index Effectively Outsources Pharmaceutical Policy Decisions to Other Countries

News
October 2019

Chronic Diseases and the Stock of Health: Quantification Using EQ-5D-5L

News
October 2019

Patient Preferences for Diagnostic Tests Aimed at Managing Antimicrobial Resistance

01
02
03
04
05
06
07
08
00

Subscribe To Our Newsletter

Our monthly Bulletin highlights our work alongside the latest from across health economics and health care.

Sign Up Now

Group 11119

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

© 2023 OHE

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Powered by GDPR Cookie Compliance

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Enable or Disable Cookies

Please enable Strictly Necessary Cookies first so that we can save your preferences!